"Kinetics" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The rate dynamics in chemical or physical systems.
Descriptor ID |
D007700
|
MeSH Number(s) |
G01.374.661 G02.111.490
|
Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Kinetics".
Below are MeSH descriptors whose meaning is more specific than "Kinetics".
This graph shows the total number of publications written about "Kinetics" by people in this website by year, and whether "Kinetics" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1995 | 0 | 4 | 4 |
1998 | 0 | 1 | 1 |
1999 | 0 | 3 | 3 |
2000 | 0 | 2 | 2 |
2002 | 0 | 1 | 1 |
2003 | 0 | 6 | 6 |
2004 | 0 | 9 | 9 |
2005 | 0 | 13 | 13 |
2006 | 0 | 6 | 6 |
2007 | 0 | 4 | 4 |
2008 | 0 | 4 | 4 |
2009 | 0 | 3 | 3 |
2010 | 0 | 3 | 3 |
2012 | 0 | 9 | 9 |
2013 | 0 | 3 | 3 |
2014 | 0 | 5 | 5 |
2015 | 0 | 3 | 3 |
2016 | 0 | 6 | 6 |
2017 | 0 | 112 | 112 |
2018 | 1 | 84 | 85 |
2019 | 0 | 42 | 42 |
2020 | 0 | 47 | 47 |
2021 | 1 | 66 | 67 |
To return to the timeline, click here.
Below are the most recent publications written about "Kinetics" by people in Profiles.
-
In silico identification of novel SARS-COV-2 2'-O-methyltransferase (nsp16) inhibitors: structure-based virtual screening, molecular dynamics simulation and MM-PBSA approaches. J Enzyme Inhib Med Chem. 2021 Dec; 36(1):727-736.
-
Kinetics of the Severe Acute Respiratory Syndrome Coronavirus 2 Antibody Response and Serological Estimation of Time Since Infection. J Infect Dis. 2021 11 16; 224(9):1489-1499.
-
Antibody Kinetics and Durability in SARS-CoV-2 mRNA Vaccinated Solid Organ Transplant Recipients. Transplantation. 2021 10 01; 105(10):e137-e138.
-
Comparison of Circulating Immune Cells Profiles and Kinetics Between Coronavirus Disease 2019 and Bacterial Sepsis. Crit Care Med. 2021 10 01; 49(10):1717-1725.
-
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Viral Load Kinetics in Symptomatic Children, Adolescents, and Adults. Clin Infect Dis. 2021 09 15; 73(6):e1384-e1386.
-
Characterization of a Novel ACE2-Based Therapeutic with Enhanced Rather than Reduced Activity against SARS-CoV-2 Variants. J Virol. 2021 09 09; 95(19):e0068521.
-
Evolution of antibody responses up to 13 months after SARS-CoV-2 infection and risk of reinfection. EBioMedicine. 2021 Sep; 71:103561.
-
Effects of common mutations in the SARS-CoV-2 Spike RBD and its ligand, the human ACE2 receptor on binding affinity and kinetics. Elife. 2021 08 26; 10.
-
Comparative kinetics of SARS-CoV-2 anti-spike protein RBD IgGs and neutralizing antibodies in convalescent and naïve recipients of the BNT162b2 mRNA vaccine versus COVID-19 patients. BMC Med. 2021 08 23; 19(1):208.
-
OFF-State-Specific Inhibition of the Proprotein Convertase Furin. ACS Chem Biol. 2021 09 17; 16(9):1692-1700.